

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of pigment cell differentiation (GO:0050932) | 6.88613668 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 5.96331281 |
| 3 | central nervous system myelination (GO:0022010) | 5.96331281 |
| 4 | presynaptic membrane assembly (GO:0097105) | 5.17103222 |
| 5 | axon ensheathment (GO:0008366) | 4.90583258 |
| 6 | ensheathment of neurons (GO:0007272) | 4.90583258 |
| 7 | presynaptic membrane organization (GO:0097090) | 4.63847894 |
| 8 | myelination in peripheral nervous system (GO:0022011) | 4.44175531 |
| 9 | peripheral nervous system axon ensheathment (GO:0032292) | 4.44175531 |
| 10 | cranial nerve structural organization (GO:0021604) | 4.39107861 |
| 11 | myelination (GO:0042552) | 4.37887186 |
| 12 | positive regulation of developmental pigmentation (GO:0048087) | 4.28093039 |
| 13 | regulation of gene silencing by RNA (GO:0060966) | 4.22951796 |
| 14 | regulation of posttranscriptional gene silencing (GO:0060147) | 4.22951796 |
| 15 | regulation of gene silencing by miRNA (GO:0060964) | 4.22951796 |
| 16 | cell-cell junction maintenance (GO:0045217) | 4.16289444 |
| 17 | postsynaptic membrane organization (GO:0001941) | 4.15213625 |
| 18 | regulation of cholesterol esterification (GO:0010872) | 3.75031891 |
| 19 | facial nerve structural organization (GO:0021612) | 3.69848144 |
| 20 | plasma lipoprotein particle assembly (GO:0034377) | 3.66405268 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 3.63745327 |
| 22 | ribosomal small subunit biogenesis (GO:0042274) | 3.58593213 |
| 23 | fatty acid elongation (GO:0030497) | 3.56406882 |
| 24 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.53583223 |
| 25 | cranial nerve morphogenesis (GO:0021602) | 3.53283098 |
| 26 | mannosylation (GO:0097502) | 3.48458540 |
| 27 | GPI anchor biosynthetic process (GO:0006506) | 3.46815335 |
| 28 | lymphoid progenitor cell differentiation (GO:0002320) | 3.45628951 |
| 29 | lysine catabolic process (GO:0006554) | 3.40076351 |
| 30 | lysine metabolic process (GO:0006553) | 3.40076351 |
| 31 | peripheral nervous system development (GO:0007422) | 3.38034909 |
| 32 | reverse cholesterol transport (GO:0043691) | 3.37309112 |
| 33 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.35167069 |
| 34 | aspartate family amino acid catabolic process (GO:0009068) | 3.32720152 |
| 35 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 3.28145308 |
| 36 | viral transcription (GO:0019083) | 3.28009138 |
| 37 | limb bud formation (GO:0060174) | 3.24052688 |
| 38 | female gonad development (GO:0008585) | 3.23862508 |
| 39 | phospholipid efflux (GO:0033700) | 3.21085904 |
| 40 | negative regulation of sterol transport (GO:0032372) | 3.20390442 |
| 41 | negative regulation of cholesterol transport (GO:0032375) | 3.20390442 |
| 42 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.19515251 |
| 43 | regulation of developmental pigmentation (GO:0048070) | 3.16161548 |
| 44 | platelet dense granule organization (GO:0060155) | 3.12670469 |
| 45 | protein heterotetramerization (GO:0051290) | 3.12522727 |
| 46 | GPI anchor metabolic process (GO:0006505) | 3.11750114 |
| 47 | developmental pigmentation (GO:0048066) | 3.11703514 |
| 48 | metanephric nephron tubule development (GO:0072234) | 3.11372594 |
| 49 | metanephric tubule development (GO:0072170) | 3.11372594 |
| 50 | mesonephros development (GO:0001823) | 3.05974372 |
| 51 | regulation of hexokinase activity (GO:1903299) | 3.04288604 |
| 52 | regulation of glucokinase activity (GO:0033131) | 3.04288604 |
| 53 | magnesium ion transport (GO:0015693) | 3.04088627 |
| 54 | short-term memory (GO:0007614) | 3.03254188 |
| 55 | serine family amino acid catabolic process (GO:0009071) | 3.00921376 |
| 56 | translational termination (GO:0006415) | 3.00654380 |
| 57 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.99699807 |
| 58 | cotranslational protein targeting to membrane (GO:0006613) | 2.97880589 |
| 59 | nephron tubule morphogenesis (GO:0072078) | 2.96785215 |
| 60 | nephron epithelium morphogenesis (GO:0072088) | 2.96785215 |
| 61 | oligodendrocyte differentiation (GO:0048709) | 2.96157282 |
| 62 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.96050710 |
| 63 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.94974865 |
| 64 | branched-chain amino acid catabolic process (GO:0009083) | 2.94698647 |
| 65 | respiratory chain complex IV assembly (GO:0008535) | 2.93703576 |
| 66 | sympathetic nervous system development (GO:0048485) | 2.92947790 |
| 67 | protein targeting to ER (GO:0045047) | 2.92662538 |
| 68 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.91910288 |
| 69 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.90922276 |
| 70 | endothelium development (GO:0003158) | 2.88950578 |
| 71 | cranial nerve development (GO:0021545) | 2.87496249 |
| 72 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.87361546 |
| 73 | detection of light stimulus involved in visual perception (GO:0050908) | 2.87361546 |
| 74 | transepithelial transport (GO:0070633) | 2.87155703 |
| 75 | nephron tubule formation (GO:0072079) | 2.86446798 |
| 76 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.86115363 |
| 77 | aldehyde catabolic process (GO:0046185) | 2.83847648 |
| 78 | response to folic acid (GO:0051593) | 2.83594274 |
| 79 | lung-associated mesenchyme development (GO:0060484) | 2.83353568 |
| 80 | protein-lipid complex assembly (GO:0065005) | 2.83090616 |
| 81 | C-terminal protein lipidation (GO:0006501) | 2.81933925 |
| 82 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.81631318 |
| 83 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.81631318 |
| 84 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.81631318 |
| 85 | anatomical structure arrangement (GO:0048532) | 2.81567553 |
| 86 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.81536450 |
| 87 | nonmotile primary cilium assembly (GO:0035058) | 2.80990715 |
| 88 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.80655028 |
| 89 | regulation of timing of cell differentiation (GO:0048505) | 2.80555497 |
| 90 | protein-cofactor linkage (GO:0018065) | 2.80089391 |
| 91 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.79822798 |
| 92 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.79480445 |
| 93 | protein localization to endoplasmic reticulum (GO:0070972) | 2.78975292 |
| 94 | regulation of cilium movement (GO:0003352) | 2.78931397 |
| 95 | glycine metabolic process (GO:0006544) | 2.78246242 |
| 96 | metanephric nephron epithelium development (GO:0072243) | 2.77843041 |
| 97 | DNA damage response, detection of DNA damage (GO:0042769) | 2.77283986 |
| 98 | neuron cell-cell adhesion (GO:0007158) | 2.76953000 |
| 99 | nephron epithelium development (GO:0072009) | 2.76381888 |
| 100 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.76128423 |
| 101 | pattern specification involved in kidney development (GO:0061004) | 2.75794108 |
| 102 | homocysteine metabolic process (GO:0050667) | 2.74527641 |
| 103 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.74424869 |
| 104 | DNA strand renaturation (GO:0000733) | 2.73143183 |
| 105 | enteric nervous system development (GO:0048484) | 2.73115441 |
| 106 | L-serine metabolic process (GO:0006563) | 2.71987082 |
| 107 | amino sugar catabolic process (GO:0046348) | 2.71121979 |
| 108 | chaperone-mediated protein transport (GO:0072321) | 2.70492859 |
| 109 | metanephric epithelium development (GO:0072207) | 2.70168300 |
| 110 | kidney morphogenesis (GO:0060993) | 2.69997140 |
| 111 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.69877012 |
| 112 | behavioral response to nicotine (GO:0035095) | 2.69453629 |
| 113 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.69220611 |
| 114 | C4-dicarboxylate transport (GO:0015740) | 2.68726446 |
| 115 | eye photoreceptor cell differentiation (GO:0001754) | 2.67861793 |
| 116 | photoreceptor cell differentiation (GO:0046530) | 2.67861793 |
| 117 | somite development (GO:0061053) | 2.67176830 |
| 118 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.66808797 |
| 119 | cholesterol biosynthetic process (GO:0006695) | 2.64928267 |
| 120 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.64486562 |
| 121 | indolalkylamine metabolic process (GO:0006586) | 2.61481371 |
| 122 | cytochrome complex assembly (GO:0017004) | 2.60949831 |
| 123 | cell junction maintenance (GO:0034331) | 2.60661241 |
| 124 | sphingoid metabolic process (GO:0046519) | 2.59787388 |
| 125 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.58767099 |
| 126 | replication fork processing (GO:0031297) | 2.58106299 |
| 127 | glyoxylate metabolic process (GO:0046487) | 2.57830743 |
| 128 | male sex determination (GO:0030238) | 2.56942199 |
| 129 | Leydig cell differentiation (GO:0033327) | 2.56507119 |
| 130 | fucose catabolic process (GO:0019317) | 2.55929349 |
| 131 | L-fucose metabolic process (GO:0042354) | 2.55929349 |
| 132 | L-fucose catabolic process (GO:0042355) | 2.55929349 |
| 133 | omega-hydroxylase P450 pathway (GO:0097267) | 2.55773169 |
| 134 | plasma lipoprotein particle remodeling (GO:0034369) | 2.55586115 |
| 135 | protein-lipid complex remodeling (GO:0034368) | 2.55586115 |
| 136 | macromolecular complex remodeling (GO:0034367) | 2.55586115 |
| 137 | response to pheromone (GO:0019236) | 2.55141746 |
| 138 | photoreceptor cell maintenance (GO:0045494) | 2.54899803 |
| 139 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.54429489 |
| 140 | polyol transport (GO:0015791) | 2.54086673 |
| 141 | excretion (GO:0007588) | 2.53901556 |
| 142 | DNA ligation (GO:0006266) | 2.52647970 |
| 143 | sterol biosynthetic process (GO:0016126) | 2.51885331 |
| 144 | negative regulation of protein localization to cell surface (GO:2000009) | 2.51849971 |
| 145 | keratinocyte development (GO:0003334) | 2.51035815 |
| 146 | serine family amino acid metabolic process (GO:0009069) | 2.48458864 |
| 147 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.47568763 |
| 148 | regulation of hippo signaling (GO:0035330) | 2.46537418 |
| 149 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.45209670 |
| 150 | cell differentiation involved in metanephros development (GO:0072202) | 2.43857960 |
| 151 | cholesterol efflux (GO:0033344) | 2.42550785 |
| 152 | regulation of development, heterochronic (GO:0040034) | 2.42361069 |
| 153 | C-terminal protein amino acid modification (GO:0018410) | 2.41808609 |
| 154 | membrane assembly (GO:0071709) | 2.41699303 |
| 155 | negative regulation of lipase activity (GO:0060192) | 2.41456107 |
| 156 | L-ascorbic acid metabolic process (GO:0019852) | 2.41455042 |
| 157 | positive regulation of synapse assembly (GO:0051965) | 2.40865260 |
| 158 | urate metabolic process (GO:0046415) | 2.40155578 |
| 159 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.39946758 |
| 160 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 2.39031246 |
| 161 | DNA double-strand break processing (GO:0000729) | 2.39011399 |
| 162 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.38897337 |
| 163 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.38897337 |
| 164 | pseudouridine synthesis (GO:0001522) | 2.38463876 |
| 165 | protein neddylation (GO:0045116) | 2.38045270 |
| 166 | serine family amino acid biosynthetic process (GO:0009070) | 2.38024806 |
| 167 | intestinal cholesterol absorption (GO:0030299) | 2.37332671 |
| 168 | L-amino acid import (GO:0043092) | 2.37176014 |
| 169 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.35165703 |
| 170 | organ growth (GO:0035265) | 2.34185183 |
| 171 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.33927152 |
| 172 | lateral sprouting from an epithelium (GO:0060601) | 2.31759987 |
| 173 | somite rostral/caudal axis specification (GO:0032525) | 2.30908690 |
| 174 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.30789781 |
| 175 | vitamin transmembrane transport (GO:0035461) | 2.29575631 |
| 176 | mast cell activation (GO:0045576) | 2.29096384 |
| 177 | kynurenine metabolic process (GO:0070189) | 2.28407976 |
| 178 | androgen biosynthetic process (GO:0006702) | 2.28043663 |
| 179 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 2.27678019 |
| 180 | glycolipid biosynthetic process (GO:0009247) | 2.27512525 |
| 181 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.27198792 |
| 182 | negative regulation of neurotransmitter transport (GO:0051589) | 2.26689512 |
| 183 | regulation of helicase activity (GO:0051095) | 2.26543642 |
| 184 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.26490536 |
| 185 | otic vesicle formation (GO:0030916) | 2.26063037 |
| 186 | plasma lipoprotein particle organization (GO:0071827) | 2.24180057 |
| 187 | lactate metabolic process (GO:0006089) | 2.23884756 |
| 188 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.23576183 |
| 189 | S-adenosylmethionine metabolic process (GO:0046500) | 2.23271642 |
| 190 | cellular modified amino acid catabolic process (GO:0042219) | 2.23142583 |
| 191 | mitochondrial RNA metabolic process (GO:0000959) | 2.22123326 |
| 192 | cullin deneddylation (GO:0010388) | 2.21259918 |
| 193 | termination of RNA polymerase III transcription (GO:0006386) | 2.20634685 |
| 194 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.20634685 |
| 195 | proteasome assembly (GO:0043248) | 2.20118326 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.05864337 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.20701601 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.76563562 |
| 4 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.62340206 |
| 5 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.48300654 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.37398749 |
| 7 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.17452337 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.11396617 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.93649563 |
| 10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.76776449 |
| 11 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.58723160 |
| 12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.54243845 |
| 13 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.53252912 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.41810493 |
| 15 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.35764900 |
| 16 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.35016238 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.34740285 |
| 18 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.33700203 |
| 19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.30709532 |
| 20 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.28910224 |
| 21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.28190014 |
| 22 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.28083239 |
| 23 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.27709574 |
| 24 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.25606046 |
| 25 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.25436882 |
| 26 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.25436882 |
| 27 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.22163505 |
| 28 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.17508431 |
| 29 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.17221238 |
| 30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.14797380 |
| 31 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.10643423 |
| 32 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.09454172 |
| 33 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 2.06888667 |
| 34 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.97443730 |
| 35 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.93334684 |
| 36 | VDR_22108803_ChIP-Seq_LS180_Human | 1.92325679 |
| 37 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.90844299 |
| 38 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.86305052 |
| 39 | EWS_26573619_Chip-Seq_HEK293_Human | 1.83573480 |
| 40 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.82776436 |
| 41 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.82645859 |
| 42 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.80856812 |
| 43 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.76351076 |
| 44 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.75899795 |
| 45 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.73520809 |
| 46 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.70562539 |
| 47 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.69961694 |
| 48 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.69566696 |
| 49 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.66151824 |
| 50 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.65195460 |
| 51 | P300_19829295_ChIP-Seq_ESCs_Human | 1.60001017 |
| 52 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.59191644 |
| 53 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.56597849 |
| 54 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.49380559 |
| 55 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.48776702 |
| 56 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.48276394 |
| 57 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.47383946 |
| 58 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.47195457 |
| 59 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.46856044 |
| 60 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.46438164 |
| 61 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.45682563 |
| 62 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.45420641 |
| 63 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.45091371 |
| 64 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.44136687 |
| 65 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.43601093 |
| 66 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.42770467 |
| 67 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.42613589 |
| 68 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.42515242 |
| 69 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.41945974 |
| 70 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.39616842 |
| 71 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.39611753 |
| 72 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.38505145 |
| 73 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.38068572 |
| 74 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.37819943 |
| 75 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.35978545 |
| 76 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.34909104 |
| 77 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.34721032 |
| 78 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.33420053 |
| 79 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.33232219 |
| 80 | FUS_26573619_Chip-Seq_HEK293_Human | 1.33058525 |
| 81 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.32344697 |
| 82 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.32323392 |
| 83 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.31516080 |
| 84 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.30847683 |
| 85 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.30576627 |
| 86 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.30412291 |
| 87 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.29613353 |
| 88 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.29561919 |
| 89 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.28741850 |
| 90 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.28497956 |
| 91 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.28440583 |
| 92 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.27697600 |
| 93 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.27428576 |
| 94 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.27349222 |
| 95 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.25669985 |
| 96 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.25323659 |
| 97 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.24992780 |
| 98 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.24992780 |
| 99 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.24787165 |
| 100 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.22724949 |
| 101 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.22696453 |
| 102 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22316910 |
| 103 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.21511106 |
| 104 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.19328358 |
| 105 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.18751402 |
| 106 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.18634961 |
| 107 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17967604 |
| 108 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.17967604 |
| 109 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.16181824 |
| 110 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.15702338 |
| 111 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14513747 |
| 112 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.13561191 |
| 113 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.13527060 |
| 114 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.12935521 |
| 115 | KDM2B_26808549_Chip-Seq_REH_Human | 1.12758651 |
| 116 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.12688724 |
| 117 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.12384497 |
| 118 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.12264783 |
| 119 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.11583157 |
| 120 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.11431417 |
| 121 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.11332117 |
| 122 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.11020099 |
| 123 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.11003640 |
| 124 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.10303609 |
| 125 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.09322765 |
| 126 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.08734818 |
| 127 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.07888978 |
| 128 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.05693534 |
| 129 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.05693534 |
| 130 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.04584346 |
| 131 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.04214840 |
| 132 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.03885529 |
| 133 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.03429874 |
| 134 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.03356668 |
| 135 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.02835622 |
| 136 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.02619932 |
| 137 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.02482372 |
| 138 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.01853124 |
| 139 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.01322506 |
| 140 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.00220033 |
| 141 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.00126356 |
| 142 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.98343989 |
| 143 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.96484366 |
| 144 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.95981400 |
| 145 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.95873344 |
| 146 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95515599 |
| 147 | * ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.95236815 |
| 148 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.95208487 |
| 149 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.95143378 |
| 150 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.95143378 |
| 151 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.94962702 |
| 152 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.94825709 |
| 153 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.93827796 |
| 154 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.93785892 |
| 155 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.93690443 |
| 156 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.91806635 |
| 157 | TCF4_23295773_ChIP-Seq_U87_Human | 0.91608354 |
| 158 | * ETV1_20927104_ChIP-Seq_GIST48_Human | 0.91285296 |
| 159 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.90279619 |
| 160 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.90019338 |
| 161 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.89863747 |
| 162 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.89815570 |
| 163 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.89294611 |
| 164 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.89033390 |
| 165 | * PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.88814180 |
| 166 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.88433090 |
| 167 | STAT3_23295773_ChIP-Seq_U87_Human | 0.88291965 |
| 168 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.88013404 |
| 169 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87936556 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003136_yellow_coat_color | 7.44664274 |
| 2 | MP0004381_abnormal_hair_follicle | 4.72249545 |
| 3 | MP0009379_abnormal_foot_pigmentation | 4.15789982 |
| 4 | MP0005409_darkened_coat_color | 3.96154181 |
| 5 | MP0002254_reproductive_system_inflammat | 3.71501590 |
| 6 | MP0000920_abnormal_myelination | 3.55887910 |
| 7 | MP0003195_calcinosis | 3.48662702 |
| 8 | MP0008260_abnormal_autophagy | 3.33062239 |
| 9 | MP0001188_hyperpigmentation | 3.18262463 |
| 10 | MP0004272_abnormal_basement_membrane | 2.93572503 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.69241920 |
| 12 | MP0003880_abnormal_central_pattern | 2.49632095 |
| 13 | MP0005171_absent_coat_pigmentation | 2.38737415 |
| 14 | MP0005075_abnormal_melanosome_morpholog | 2.37991433 |
| 15 | MP0003122_maternal_imprinting | 2.35505443 |
| 16 | MP0010030_abnormal_orbit_morphology | 2.33652218 |
| 17 | MP0005174_abnormal_tail_pigmentation | 2.22811392 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.20603485 |
| 19 | MP0006292_abnormal_olfactory_placode | 2.18975667 |
| 20 | MP0004133_heterotaxia | 2.14943228 |
| 21 | MP0008877_abnormal_DNA_methylation | 2.08734806 |
| 22 | MP0003315_abnormal_perineum_morphology | 2.07301785 |
| 23 | MP0002938_white_spotting | 2.03170306 |
| 24 | MP0003567_abnormal_fetal_cardiomyocyte | 1.96457380 |
| 25 | MP0002272_abnormal_nervous_system | 1.96005941 |
| 26 | MP0004019_abnormal_vitamin_homeostasis | 1.92243565 |
| 27 | MP0003878_abnormal_ear_physiology | 1.85272859 |
| 28 | MP0005377_hearing/vestibular/ear_phenot | 1.85272859 |
| 29 | MP0001293_anophthalmia | 1.82338961 |
| 30 | MP0001986_abnormal_taste_sensitivity | 1.81216914 |
| 31 | MP0003941_abnormal_skin_development | 1.80556042 |
| 32 | MP0001661_extended_life_span | 1.79734012 |
| 33 | MP0001984_abnormal_olfaction | 1.72669416 |
| 34 | MP0003718_maternal_effect | 1.71415165 |
| 35 | MP0005394_taste/olfaction_phenotype | 1.71053044 |
| 36 | MP0005499_abnormal_olfactory_system | 1.71053044 |
| 37 | MP0003890_abnormal_embryonic-extraembry | 1.68220567 |
| 38 | MP0000015_abnormal_ear_pigmentation | 1.67951464 |
| 39 | MP0004742_abnormal_vestibular_system | 1.66963230 |
| 40 | MP0008789_abnormal_olfactory_epithelium | 1.66497197 |
| 41 | MP0003724_increased_susceptibility_to | 1.66432319 |
| 42 | MP0001529_abnormal_vocalization | 1.65541944 |
| 43 | MP0002095_abnormal_skin_pigmentation | 1.64712336 |
| 44 | MP0002067_abnormal_sensory_capabilities | 1.58602958 |
| 45 | MP0002734_abnormal_mechanical_nocicepti | 1.57510492 |
| 46 | MP0000372_irregular_coat_pigmentation | 1.57199316 |
| 47 | MP0004145_abnormal_muscle_electrophysio | 1.56362299 |
| 48 | * MP0003634_abnormal_glial_cell | 1.56235578 |
| 49 | MP0004142_abnormal_muscle_tone | 1.50698483 |
| 50 | MP0005423_abnormal_somatic_nervous | 1.48143019 |
| 51 | MP0005332_abnormal_amino_acid | 1.46667300 |
| 52 | MP0003937_abnormal_limbs/digits/tail_de | 1.45314410 |
| 53 | MP0000566_synostosis | 1.43162757 |
| 54 | MP0003119_abnormal_digestive_system | 1.42819262 |
| 55 | MP0002233_abnormal_nose_morphology | 1.39030191 |
| 56 | MP0010329_abnormal_lipoprotein_level | 1.34592502 |
| 57 | MP0002009_preneoplasia | 1.32005616 |
| 58 | MP0001756_abnormal_urination | 1.31667113 |
| 59 | MP0004270_analgesia | 1.29674126 |
| 60 | MP0003186_abnormal_redox_activity | 1.28514046 |
| 61 | MP0000647_abnormal_sebaceous_gland | 1.26997568 |
| 62 | MP0001286_abnormal_eye_development | 1.26287833 |
| 63 | MP0003121_genomic_imprinting | 1.25522215 |
| 64 | MP0003938_abnormal_ear_development | 1.25516324 |
| 65 | MP0006072_abnormal_retinal_apoptosis | 1.24877244 |
| 66 | MP0005636_abnormal_mineral_homeostasis | 1.24864953 |
| 67 | MP0000751_myopathy | 1.24522913 |
| 68 | MP0001486_abnormal_startle_reflex | 1.24377350 |
| 69 | MP0002102_abnormal_ear_morphology | 1.23596702 |
| 70 | MP0005084_abnormal_gallbladder_morpholo | 1.22364609 |
| 71 | MP0002751_abnormal_autonomic_nervous | 1.18913037 |
| 72 | MP0001324_abnormal_eye_pigmentation | 1.18389992 |
| 73 | MP0008872_abnormal_physiological_respon | 1.18185414 |
| 74 | MP0002234_abnormal_pharynx_morphology | 1.14045545 |
| 75 | MP0008569_lethality_at_weaning | 1.13791294 |
| 76 | MP0003693_abnormal_embryo_hatching | 1.13625167 |
| 77 | MP0001963_abnormal_hearing_physiology | 1.12701651 |
| 78 | MP0008875_abnormal_xenobiotic_pharmacok | 1.11379561 |
| 79 | MP0000026_abnormal_inner_ear | 1.11082596 |
| 80 | MP0009046_muscle_twitch | 1.11053834 |
| 81 | MP0001970_abnormal_pain_threshold | 1.10842930 |
| 82 | MP0003045_fibrosis | 1.09557075 |
| 83 | MP0001666_abnormal_nutrient_absorption | 1.08312754 |
| 84 | MP0008058_abnormal_DNA_repair | 1.07975005 |
| 85 | MP0006276_abnormal_autonomic_nervous | 1.07845197 |
| 86 | MP0005646_abnormal_pituitary_gland | 1.07508196 |
| 87 | MP0003011_delayed_dark_adaptation | 1.07426158 |
| 88 | MP0001905_abnormal_dopamine_level | 1.06457159 |
| 89 | MP0002736_abnormal_nociception_after | 1.05058019 |
| 90 | MP0000049_abnormal_middle_ear | 1.03372888 |
| 91 | MP0002733_abnormal_thermal_nociception | 1.03050958 |
| 92 | MP0005391_vision/eye_phenotype | 1.01539266 |
| 93 | MP0003787_abnormal_imprinting | 1.01446516 |
| 94 | MP0000778_abnormal_nervous_system | 1.00924912 |
| 95 | MP0005365_abnormal_bile_salt | 1.00904069 |
| 96 | MP0005360_urolithiasis | 1.00225980 |
| 97 | MP0004264_abnormal_extraembryonic_tissu | 0.99939513 |
| 98 | MP0001764_abnormal_homeostasis | 0.99441575 |
| 99 | MP0003950_abnormal_plasma_membrane | 0.99093798 |
| 100 | MP0000516_abnormal_urinary_system | 0.98290392 |
| 101 | MP0005367_renal/urinary_system_phenotyp | 0.98290392 |
| 102 | MP0000631_abnormal_neuroendocrine_gland | 0.98223666 |
| 103 | MP0005408_hypopigmentation | 0.98091327 |
| 104 | MP0002697_abnormal_eye_size | 0.97285003 |
| 105 | MP0004147_increased_porphyrin_level | 0.95016051 |
| 106 | MP0002752_abnormal_somatic_nervous | 0.94355708 |
| 107 | MP0002229_neurodegeneration | 0.92642463 |
| 108 | MP0001485_abnormal_pinna_reflex | 0.92163272 |
| 109 | MP0002638_abnormal_pupillary_reflex | 0.91463231 |
| 110 | MP0005551_abnormal_eye_electrophysiolog | 0.91202717 |
| 111 | MP0003755_abnormal_palate_morphology | 0.90592666 |
| 112 | MP0004885_abnormal_endolymph | 0.90084114 |
| 113 | MP0002557_abnormal_social/conspecific_i | 0.89977859 |
| 114 | MP0008995_early_reproductive_senescence | 0.89509375 |
| 115 | MP0009697_abnormal_copulation | 0.89070537 |
| 116 | MP0002177_abnormal_outer_ear | 0.88905417 |
| 117 | MP0002090_abnormal_vision | 0.88147861 |
| 118 | MP0005195_abnormal_posterior_eye | 0.87188337 |
| 119 | MP0000749_muscle_degeneration | 0.87059282 |
| 120 | MP0002249_abnormal_larynx_morphology | 0.84924525 |
| 121 | MP0002064_seizures | 0.84634597 |
| 122 | MP0008438_abnormal_cutaneous_collagen | 0.84428658 |
| 123 | MP0009643_abnormal_urine_homeostasis | 0.82930749 |
| 124 | MP0009672_abnormal_birth_weight | 0.82846458 |
| 125 | MP0000538_abnormal_urinary_bladder | 0.81875238 |
| 126 | MP0002876_abnormal_thyroid_physiology | 0.80404663 |
| 127 | MP0003123_paternal_imprinting | 0.79803290 |
| 128 | MP0003252_abnormal_bile_duct | 0.79086824 |
| 129 | MP0009703_decreased_birth_body | 0.78721762 |
| 130 | MP0005410_abnormal_fertilization | 0.78199079 |
| 131 | MP0005085_abnormal_gallbladder_physiolo | 0.78123311 |
| 132 | MP0001299_abnormal_eye_distance/ | 0.77759664 |
| 133 | MP0005645_abnormal_hypothalamus_physiol | 0.75968452 |
| 134 | MP0005595_abnormal_vascular_smooth | 0.75418639 |
| 135 | MP0003632_abnormal_nervous_system | 0.75047411 |
| 136 | MP0000762_abnormal_tongue_morphology | 0.74266108 |
| 137 | MP0002148_abnormal_hypersensitivity_rea | 0.74244360 |
| 138 | MP0009745_abnormal_behavioral_response | 0.74089832 |
| 139 | MP0002277_abnormal_respiratory_mucosa | 0.73991579 |
| 140 | MP0004957_abnormal_blastocyst_morpholog | 0.73517066 |
| 141 | MP0002735_abnormal_chemical_nociception | 0.72848495 |
| 142 | MP0000653_abnormal_sex_gland | 0.72385331 |
| 143 | MP0009250_abnormal_appendicular_skeleto | 0.72219711 |
| 144 | MP0000465_gastrointestinal_hemorrhage | 0.72035312 |
| 145 | MP0002084_abnormal_developmental_patter | 0.71921650 |
| 146 | MP0002882_abnormal_neuron_morphology | 0.71711207 |
| 147 | MP0002282_abnormal_trachea_morphology | 0.71455617 |
| 148 | MP0002160_abnormal_reproductive_system | 0.71345748 |
| 149 | MP0005253_abnormal_eye_physiology | 0.70031070 |
| 150 | MP0001186_pigmentation_phenotype | 0.69631537 |
| 151 | MP0002184_abnormal_innervation | 0.69234297 |
| 152 | MP0003631_nervous_system_phenotype | 0.69136717 |
| 153 | MP0000681_abnormal_thyroid_gland | 0.68983072 |
| 154 | MP0005379_endocrine/exocrine_gland_phen | 0.68556289 |
| 155 | MP0004043_abnormal_pH_regulation | 0.67887913 |
| 156 | MP0003635_abnormal_synaptic_transmissio | 0.67810945 |
| 157 | MP0000747_muscle_weakness | 0.67679730 |
| 158 | MP0000613_abnormal_salivary_gland | 0.67052807 |
| 159 | MP0002572_abnormal_emotion/affect_behav | 0.66713792 |
| 160 | MP0000383_abnormal_hair_follicle | 0.64961665 |
| 161 | MP0002075_abnormal_coat/hair_pigmentati | 0.61878477 |
| 162 | MP0003633_abnormal_nervous_system | 0.61110510 |
| 163 | MP0009384_cardiac_valve_regurgitation | 0.59193634 |
| 164 | MP0005623_abnormal_meninges_morphology | 0.58974723 |
| 165 | MP0010771_integument_phenotype | 0.58447171 |
| 166 | MP0002933_joint_inflammation | 0.56568286 |
| 167 | MP0003690_abnormal_glial_cell | 0.54964992 |
| 168 | MP0000579_abnormal_nail_morphology | 0.53549934 |
| 169 | MP0001664_abnormal_digestion | 0.53088938 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Segmental peripheral demyelination/remyelination (HP:0003481) | 9.91625926 |
| 2 | Impaired proprioception (HP:0010831) | 8.10700301 |
| 3 | Insidious onset (HP:0003587) | 7.16388089 |
| 4 | Termporal pattern (HP:0011008) | 7.16388089 |
| 5 | Peripheral hypomyelination (HP:0007182) | 6.24537510 |
| 6 | Action tremor (HP:0002345) | 6.00198453 |
| 7 | Upper limb muscle weakness (HP:0003484) | 5.66551767 |
| 8 | Steppage gait (HP:0003376) | 5.16010073 |
| 9 | Onion bulb formation (HP:0003383) | 4.96944747 |
| 10 | Increased CSF protein (HP:0002922) | 4.85455771 |
| 11 | Abnormal pupillary function (HP:0007686) | 4.52701402 |
| 12 | Sex reversal (HP:0012245) | 4.08153688 |
| 13 | Abnormal sex determination (HP:0012244) | 4.08153688 |
| 14 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 4.06486454 |
| 15 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 4.04014054 |
| 16 | Decreased motor nerve conduction velocity (HP:0003431) | 3.53484486 |
| 17 | Abnormality of the vocal cords (HP:0008777) | 3.53481360 |
| 18 | Peripheral demyelination (HP:0011096) | 3.52565271 |
| 19 | Abnormality of the labia minora (HP:0012880) | 3.52365125 |
| 20 | Abnormal urine output (HP:0012590) | 3.33271685 |
| 21 | Foot dorsiflexor weakness (HP:0009027) | 3.30588896 |
| 22 | Hyperactive renin-angiotensin system (HP:0000841) | 3.30172266 |
| 23 | Hammertoe (HP:0001765) | 3.26273185 |
| 24 | Renal salt wasting (HP:0000127) | 3.14921681 |
| 25 | Postural tremor (HP:0002174) | 3.12646711 |
| 26 | Abnormal drinking behavior (HP:0030082) | 3.03420617 |
| 27 | Polydipsia (HP:0001959) | 3.03420617 |
| 28 | Hyperglycinemia (HP:0002154) | 3.02851666 |
| 29 | Abnormality of the foot musculature (HP:0001436) | 2.99909285 |
| 30 | Type I transferrin isoform profile (HP:0003642) | 2.96605113 |
| 31 | Parakeratosis (HP:0001036) | 2.94195036 |
| 32 | Abnormality of the axillary hair (HP:0100134) | 2.84740469 |
| 33 | Abnormality of secondary sexual hair (HP:0009888) | 2.84740469 |
| 34 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.82592764 |
| 35 | Abnormality of renal excretion (HP:0011036) | 2.82375060 |
| 36 | Bifid tongue (HP:0010297) | 2.82067317 |
| 37 | Hyperglycinuria (HP:0003108) | 2.69466181 |
| 38 | Tetany (HP:0001281) | 2.67815756 |
| 39 | Reduced antithrombin III activity (HP:0001976) | 2.67740739 |
| 40 | Pancreatic cysts (HP:0001737) | 2.63355793 |
| 41 | Intestinal atresia (HP:0011100) | 2.62768822 |
| 42 | Hypoplasia of the uterus (HP:0000013) | 2.61577799 |
| 43 | Chronic hepatic failure (HP:0100626) | 2.61051638 |
| 44 | Metabolic alkalosis (HP:0200114) | 2.58113269 |
| 45 | Hepatoblastoma (HP:0002884) | 2.56957056 |
| 46 | Congenital stationary night blindness (HP:0007642) | 2.50091531 |
| 47 | Bilateral microphthalmos (HP:0007633) | 2.48672068 |
| 48 | Abnormality of renin-angiotensin system (HP:0000847) | 2.44369375 |
| 49 | Molar tooth sign on MRI (HP:0002419) | 2.44237683 |
| 50 | Abnormality of midbrain morphology (HP:0002418) | 2.44237683 |
| 51 | White forelock (HP:0002211) | 2.36986976 |
| 52 | Renal Fanconi syndrome (HP:0001994) | 2.35649510 |
| 53 | Patchy hypopigmentation of hair (HP:0011365) | 2.34912106 |
| 54 | Abnormality of urine glucose concentration (HP:0011016) | 2.32282608 |
| 55 | Glycosuria (HP:0003076) | 2.32282608 |
| 56 | Pendular nystagmus (HP:0012043) | 2.31165937 |
| 57 | Spontaneous abortion (HP:0005268) | 2.29596361 |
| 58 | Abolished electroretinogram (ERG) (HP:0000550) | 2.28733953 |
| 59 | Proximal tubulopathy (HP:0000114) | 2.25296868 |
| 60 | Acute encephalopathy (HP:0006846) | 2.25014739 |
| 61 | Abnormality of the renal cortex (HP:0011035) | 2.24530538 |
| 62 | True hermaphroditism (HP:0010459) | 2.24311283 |
| 63 | Generalized aminoaciduria (HP:0002909) | 2.24189610 |
| 64 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.23492564 |
| 65 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.23071521 |
| 66 | Vaginal atresia (HP:0000148) | 2.23045020 |
| 67 | Hypothermia (HP:0002045) | 2.21870540 |
| 68 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.21522957 |
| 69 | Abnormality of glycine metabolism (HP:0010895) | 2.21522957 |
| 70 | Abnormality of the renal medulla (HP:0100957) | 2.20680164 |
| 71 | Alkalosis (HP:0001948) | 2.20658461 |
| 72 | Abnormal auditory evoked potentials (HP:0006958) | 2.19220621 |
| 73 | Genital tract atresia (HP:0001827) | 2.18389637 |
| 74 | Aplasia cutis congenita (HP:0001057) | 2.15418370 |
| 75 | Nephrogenic diabetes insipidus (HP:0009806) | 2.12530855 |
| 76 | Pancreatic fibrosis (HP:0100732) | 2.12361572 |
| 77 | Increased hepatocellular lipid droplets (HP:0006565) | 2.11149769 |
| 78 | Increased corneal curvature (HP:0100692) | 2.10768348 |
| 79 | Keratoconus (HP:0000563) | 2.10768348 |
| 80 | Thyroid-stimulating hormone excess (HP:0002925) | 2.08666352 |
| 81 | Absent eyebrow (HP:0002223) | 2.06017167 |
| 82 | Medial flaring of the eyebrow (HP:0010747) | 2.04790593 |
| 83 | Progressive sensorineural hearing impairment (HP:0000408) | 2.03396472 |
| 84 | Abnormal number of erythroid precursors (HP:0012131) | 2.03394370 |
| 85 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.02384069 |
| 86 | Ulnar claw (HP:0001178) | 12.3334583 |
| 87 | Renal cortical cysts (HP:0000803) | 1.99289343 |
| 88 | * Abnormality of magnesium homeostasis (HP:0004921) | 1.99275419 |
| 89 | Reticulocytopenia (HP:0001896) | 1.98646586 |
| 90 | Hypobetalipoproteinemia (HP:0003563) | 1.97927000 |
| 91 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.97765252 |
| 92 | Split foot (HP:0001839) | 1.95739844 |
| 93 | Hypokalemia (HP:0002900) | 1.94979335 |
| 94 | Acute necrotizing encephalopathy (HP:0006965) | 1.94356733 |
| 95 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.93154778 |
| 96 | Hypokalemic alkalosis (HP:0001949) | 1.91589108 |
| 97 | Labial hypoplasia (HP:0000066) | 1.91300025 |
| 98 | Renal hypoplasia (HP:0000089) | 1.91014758 |
| 99 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.90420135 |
| 100 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.90420135 |
| 101 | Abnormal protein glycosylation (HP:0012346) | 1.90420135 |
| 102 | Abnormal glycosylation (HP:0012345) | 1.90420135 |
| 103 | Nonprogressive disorder (HP:0003680) | 1.88318200 |
| 104 | Increased circulating renin level (HP:0000848) | 1.88146662 |
| 105 | Type II lissencephaly (HP:0007260) | 1.87827529 |
| 106 | Colon cancer (HP:0003003) | 1.87760002 |
| 107 | Broad-based gait (HP:0002136) | 1.87507503 |
| 108 | Abnormality of alanine metabolism (HP:0010916) | 1.87460729 |
| 109 | Hyperalaninemia (HP:0003348) | 1.87460729 |
| 110 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.87460729 |
| 111 | Atrophic scars (HP:0001075) | 1.87307813 |
| 112 | * Hypomagnesemia (HP:0002917) | 1.87114718 |
| 113 | Enlarged kidneys (HP:0000105) | 1.86049561 |
| 114 | Cerebellar dysplasia (HP:0007033) | 1.85951410 |
| 115 | Gastrointestinal atresia (HP:0002589) | 1.85772501 |
| 116 | Bicornuate uterus (HP:0000813) | 1.84362908 |
| 117 | Abnormality of serum amino acid levels (HP:0003112) | 1.84010121 |
| 118 | Gout (HP:0001997) | 1.82615594 |
| 119 | Anophthalmia (HP:0000528) | 1.82074620 |
| 120 | Nephronophthisis (HP:0000090) | 1.81890010 |
| 121 | Hypoplastic female external genitalia (HP:0012815) | 1.81493970 |
| 122 | Retinal dysplasia (HP:0007973) | 1.81354158 |
| 123 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.80457472 |
| 124 | Retinal atrophy (HP:0001105) | 1.80292150 |
| 125 | Abnormality of renal resorption (HP:0011038) | 1.77940470 |
| 126 | Attenuation of retinal blood vessels (HP:0007843) | 1.77212071 |
| 127 | Concave nail (HP:0001598) | 1.76988340 |
| 128 | Choanal stenosis (HP:0000452) | 1.76831633 |
| 129 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.75412608 |
| 130 | Absent/shortened dynein arms (HP:0200106) | 1.75412608 |
| 131 | Congenital primary aphakia (HP:0007707) | 1.75263625 |
| 132 | Gait imbalance (HP:0002141) | 1.74491484 |
| 133 | Gonadal dysgenesis (HP:0000133) | 1.74344554 |
| 134 | Septo-optic dysplasia (HP:0100842) | 1.73426499 |
| 135 | 3-Methylglutaconic aciduria (HP:0003535) | 1.73302170 |
| 136 | Aqueductal stenosis (HP:0002410) | 1.72629743 |
| 137 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.71602034 |
| 138 | Tubular atrophy (HP:0000092) | 1.71356919 |
| 139 | Absent septum pellucidum (HP:0001331) | 1.70868348 |
| 140 | Increased CSF lactate (HP:0002490) | 1.69846090 |
| 141 | Cystic liver disease (HP:0006706) | 1.68295989 |
| 142 | Facial cleft (HP:0002006) | 1.67715978 |
| 143 | Cupped ear (HP:0000378) | 1.67336476 |
| 144 | Macrocytic anemia (HP:0001972) | 1.67213566 |
| 145 | Esophageal atresia (HP:0002032) | 1.66641881 |
| 146 | Hypoglycemic coma (HP:0001325) | 1.66458741 |
| 147 | Scrotal hypoplasia (HP:0000046) | 1.65785033 |
| 148 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.65756380 |
| 149 | Prolonged partial thromboplastin time (HP:0003645) | 1.65427228 |
| 150 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.64669064 |
| 151 | * Hypercalciuria (HP:0002150) | 1.64357633 |
| 152 | Lipid accumulation in hepatocytes (HP:0006561) | 1.63005641 |
| 153 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.62940280 |
| 154 | Abnormality of the pupil (HP:0000615) | 1.62519022 |
| 155 | Intrahepatic cholestasis (HP:0001406) | 1.60970067 |
| 156 | Hepatocellular necrosis (HP:0001404) | 1.58521900 |
| 157 | Nasolacrimal duct obstruction (HP:0000579) | 1.58356864 |
| 158 | Amelogenesis imperfecta (HP:0000705) | 1.58245421 |
| 159 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.58175708 |
| 160 | Mitochondrial inheritance (HP:0001427) | 1.56898748 |
| 161 | Abnormality of the septum pellucidum (HP:0007375) | 1.56387719 |
| 162 | Lissencephaly (HP:0001339) | 1.55934847 |
| 163 | Optic disc pallor (HP:0000543) | 1.55736648 |
| 164 | Abnormal ciliary motility (HP:0012262) | 1.53139757 |
| 165 | Optic nerve hypoplasia (HP:0000609) | 1.52296960 |
| 166 | Alacrima (HP:0000522) | 1.51544418 |
| 167 | Distal sensory impairment (HP:0002936) | 1.50461580 |
| 168 | Exertional dyspnea (HP:0002875) | 1.49934277 |
| 169 | Decreased central vision (HP:0007663) | 1.48796928 |
| 170 | Fragile skin (HP:0001030) | 1.47976641 |
| 171 | Kyphoscoliosis (HP:0002751) | 1.46179545 |
| 172 | Short tibia (HP:0005736) | 1.44452250 |
| 173 | Conical tooth (HP:0000698) | 1.43180681 |
| 174 | Flat occiput (HP:0005469) | 1.42161226 |
| 175 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.41888354 |
| 176 | Focal motor seizures (HP:0011153) | 1.41094933 |
| 177 | Polyuria (HP:0000103) | 1.40900573 |
| 178 | Stomatitis (HP:0010280) | 1.40883381 |
| 179 | Male pseudohermaphroditism (HP:0000037) | 1.40630747 |
| 180 | Hyperaldosteronism (HP:0000859) | 1.39066335 |
| 181 | Anhidrosis (HP:0000970) | 1.38568016 |
| 182 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.37704243 |
| 183 | Abnormality of chloride homeostasis (HP:0011422) | 1.37430765 |
| 184 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.37004884 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 5.33967014 |
| 2 | CASK | 4.73323795 |
| 3 | IRAK2 | 3.36945278 |
| 4 | MKNK2 | 2.98961586 |
| 5 | STK39 | 2.96964106 |
| 6 | MUSK | 2.89318829 |
| 7 | IRAK1 | 2.66930117 |
| 8 | FRK | 2.66490059 |
| 9 | ZAK | 2.62123993 |
| 10 | STK16 | 2.58182553 |
| 11 | TRIM28 | 2.41292513 |
| 12 | PDK2 | 2.39652577 |
| 13 | OXSR1 | 2.33354183 |
| 14 | EIF2AK3 | 2.18224192 |
| 15 | FGFR2 | 2.14890059 |
| 16 | BLK | 2.05089959 |
| 17 | TLK1 | 2.04794287 |
| 18 | PINK1 | 1.97762206 |
| 19 | WNK4 | 1.90278976 |
| 20 | FES | 1.86059151 |
| 21 | MKNK1 | 1.81475589 |
| 22 | MAP4K2 | 1.81152677 |
| 23 | CDK19 | 1.74880424 |
| 24 | NLK | 1.67791781 |
| 25 | BCKDK | 1.65554266 |
| 26 | IRAK4 | 1.64050028 |
| 27 | IRAK3 | 1.62863415 |
| 28 | MST4 | 1.59936542 |
| 29 | NME2 | 1.56779063 |
| 30 | BMPR1B | 1.50524826 |
| 31 | YES1 | 1.48649313 |
| 32 | PBK | 1.48020274 |
| 33 | UHMK1 | 1.34075837 |
| 34 | CLK1 | 1.33198068 |
| 35 | BCR | 1.29984024 |
| 36 | PKN1 | 1.26115643 |
| 37 | PLK3 | 1.23703471 |
| 38 | MAPK13 | 1.23453153 |
| 39 | ADRBK2 | 1.18004922 |
| 40 | EPHB1 | 1.15915001 |
| 41 | TSSK6 | 1.15542826 |
| 42 | MAPKAPK5 | 1.14392938 |
| 43 | TEC | 1.13833498 |
| 44 | FLT3 | 1.13506245 |
| 45 | STK38L | 1.13310565 |
| 46 | VRK2 | 1.12753169 |
| 47 | MAPK15 | 1.12233189 |
| 48 | TTK | 1.11207884 |
| 49 | WNK3 | 1.11103805 |
| 50 | EIF2AK2 | 1.09160681 |
| 51 | ACVR1B | 1.09120294 |
| 52 | PLK4 | 1.05645531 |
| 53 | MAP2K7 | 1.02864799 |
| 54 | MARK2 | 1.00722775 |
| 55 | CAMKK2 | 0.99172558 |
| 56 | PRPF4B | 0.93151822 |
| 57 | PLK2 | 0.91592943 |
| 58 | PRKD2 | 0.91215185 |
| 59 | TGFBR1 | 0.90070906 |
| 60 | MAP3K4 | 0.89917404 |
| 61 | VRK1 | 0.89731809 |
| 62 | BUB1 | 0.87943958 |
| 63 | GRK1 | 0.87357100 |
| 64 | AKT3 | 0.84881215 |
| 65 | PRKCG | 0.83247715 |
| 66 | KIT | 0.82578752 |
| 67 | GRK7 | 0.82049725 |
| 68 | FGFR1 | 0.81475938 |
| 69 | SRPK1 | 0.76943691 |
| 70 | CDK3 | 0.76090520 |
| 71 | NEK1 | 0.75624090 |
| 72 | MAP3K12 | 0.75526747 |
| 73 | CAMK2B | 0.75509677 |
| 74 | CAMK1 | 0.75319503 |
| 75 | SGK2 | 0.74997202 |
| 76 | RIPK4 | 0.74971119 |
| 77 | INSRR | 0.73093275 |
| 78 | CSNK1G1 | 0.72012044 |
| 79 | WNK1 | 0.70420128 |
| 80 | SGK223 | 0.69725313 |
| 81 | SGK494 | 0.69725313 |
| 82 | PLK1 | 0.69167374 |
| 83 | ATR | 0.67946001 |
| 84 | FGR | 0.66015341 |
| 85 | PAK3 | 0.65911012 |
| 86 | PIM2 | 0.65494809 |
| 87 | CSNK1G3 | 0.64993160 |
| 88 | EPHA4 | 0.64617749 |
| 89 | DYRK2 | 0.64028900 |
| 90 | BRSK2 | 0.63004494 |
| 91 | CSNK1A1 | 0.62185595 |
| 92 | TXK | 0.59347838 |
| 93 | WEE1 | 0.58270343 |
| 94 | PRKCI | 0.58170751 |
| 95 | NEK6 | 0.57937351 |
| 96 | CSK | 0.57864209 |
| 97 | LYN | 0.57105198 |
| 98 | CSNK1A1L | 0.57051095 |
| 99 | TIE1 | 0.56443469 |
| 100 | BMPR2 | 0.55233711 |
| 101 | BTK | 0.54073458 |
| 102 | HIPK2 | 0.54027132 |
| 103 | PRKCE | 0.52449794 |
| 104 | TNK2 | 0.52178074 |
| 105 | STK3 | 0.51859188 |
| 106 | CAMK2A | 0.51412288 |
| 107 | BRD4 | 0.51103566 |
| 108 | ADRBK1 | 0.50848468 |
| 109 | LCK | 0.50691297 |
| 110 | CAMK2D | 0.49381290 |
| 111 | ROCK2 | 0.49252374 |
| 112 | FER | 0.48479386 |
| 113 | CDC7 | 0.48442212 |
| 114 | ATM | 0.47979484 |
| 115 | CSNK1D | 0.47024600 |
| 116 | MST1R | 0.44672376 |
| 117 | MAP2K2 | 0.43661214 |
| 118 | MINK1 | 0.43450319 |
| 119 | CSNK1E | 0.42790738 |
| 120 | DYRK1A | 0.42455027 |
| 121 | CSNK1G2 | 0.42293852 |
| 122 | ERBB2 | 0.42130358 |
| 123 | MAPK4 | 0.40991951 |
| 124 | PRKCQ | 0.39719920 |
| 125 | LIMK1 | 0.38049525 |
| 126 | TYRO3 | 0.37868985 |
| 127 | NTRK3 | 0.37433076 |
| 128 | CHEK2 | 0.36711290 |
| 129 | ERBB4 | 0.36555018 |
| 130 | RPS6KA4 | 0.36380905 |
| 131 | PRKCZ | 0.35910592 |
| 132 | PRKACA | 0.35009307 |
| 133 | DYRK3 | 0.34149324 |
| 134 | FYN | 0.34145180 |
| 135 | MET | 0.33499685 |
| 136 | GRK5 | 0.32969239 |
| 137 | PIK3CG | 0.32648657 |
| 138 | CDK5 | 0.32391808 |
| 139 | NME1 | 0.32321654 |
| 140 | GSK3A | 0.32204918 |
| 141 | DAPK2 | 0.32014563 |
| 142 | RPS6KA5 | 0.31898806 |
| 143 | PRKG1 | 0.31826455 |
| 144 | IKBKB | 0.31362557 |
| 145 | PHKG1 | 0.30972332 |
| 146 | PHKG2 | 0.30972332 |
| 147 | MARK1 | 0.30564259 |
| 148 | SIK3 | 0.30162726 |
| 149 | CSNK2A1 | 0.30013650 |
| 150 | PRKACB | 0.29755908 |
| 151 | MAP3K14 | 0.29428372 |
| 152 | MATK | 0.28970809 |
| 153 | PRKAA1 | 0.28393985 |
| 154 | NUAK1 | 0.26571568 |
| 155 | CAMK2G | 0.26515214 |
| 156 | NEK2 | 0.26406550 |
| 157 | PNCK | 0.25712194 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 3.54966592 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.05354153 |
| 3 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.61593960 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.52038847 |
| 5 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.45215201 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.38739734 |
| 7 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.37039848 |
| 8 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.36935249 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.33268025 |
| 10 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.18417188 |
| 11 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.15033189 |
| 12 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.09710587 |
| 13 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.07104604 |
| 14 | Proteasome_Homo sapiens_hsa03050 | 2.05898650 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.00282176 |
| 16 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.99982265 |
| 17 | Phototransduction_Homo sapiens_hsa04744 | 1.98291951 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.97600656 |
| 19 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.92762113 |
| 20 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.92192231 |
| 21 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.86029349 |
| 22 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.72346857 |
| 23 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.71738538 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.69390763 |
| 25 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.66550235 |
| 26 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.64275405 |
| 27 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.63154043 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.57260978 |
| 29 | Parkinsons disease_Homo sapiens_hsa05012 | 1.57194524 |
| 30 | Alzheimers disease_Homo sapiens_hsa05010 | 1.57162463 |
| 31 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.56280480 |
| 32 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.50783119 |
| 33 | Axon guidance_Homo sapiens_hsa04360 | 1.49926121 |
| 34 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.49794475 |
| 35 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.43468045 |
| 36 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.42862463 |
| 37 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.42393283 |
| 38 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.41140769 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41081539 |
| 40 | Nicotine addiction_Homo sapiens_hsa05033 | 1.40115121 |
| 41 | Peroxisome_Homo sapiens_hsa04146 | 1.36661502 |
| 42 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.35477730 |
| 43 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.33217949 |
| 44 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.28276471 |
| 45 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.27731726 |
| 46 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.27482807 |
| 47 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.27064273 |
| 48 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.21847851 |
| 49 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.21325497 |
| 50 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.21055292 |
| 51 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.19646204 |
| 52 | RNA degradation_Homo sapiens_hsa03018 | 1.18637834 |
| 53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.17898532 |
| 54 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.14507804 |
| 55 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.13896379 |
| 56 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.13182024 |
| 57 | Taste transduction_Homo sapiens_hsa04742 | 1.11109590 |
| 58 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.10743678 |
| 59 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.09389114 |
| 60 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.07572870 |
| 61 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.03964044 |
| 62 | Long-term depression_Homo sapiens_hsa04730 | 1.03923500 |
| 63 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.03858058 |
| 64 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.03705203 |
| 65 | Huntingtons disease_Homo sapiens_hsa05016 | 1.03651778 |
| 66 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.03601571 |
| 67 | Base excision repair_Homo sapiens_hsa03410 | 1.01751374 |
| 68 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.00041902 |
| 69 | Homologous recombination_Homo sapiens_hsa03440 | 0.99368695 |
| 70 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.97878135 |
| 71 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.96614750 |
| 72 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.95377253 |
| 73 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.95370237 |
| 74 | Mismatch repair_Homo sapiens_hsa03430 | 0.94977042 |
| 75 | Asthma_Homo sapiens_hsa05310 | 0.94787149 |
| 76 | Histidine metabolism_Homo sapiens_hsa00340 | 0.94254847 |
| 77 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.93161659 |
| 78 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.89818764 |
| 79 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.89492593 |
| 80 | RNA polymerase_Homo sapiens_hsa03020 | 0.87267344 |
| 81 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.85662128 |
| 82 | Malaria_Homo sapiens_hsa05144 | 0.85536598 |
| 83 | RNA transport_Homo sapiens_hsa03013 | 0.84228533 |
| 84 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.83970712 |
| 85 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.83358163 |
| 86 | Allograft rejection_Homo sapiens_hsa05330 | 0.81420883 |
| 87 | Morphine addiction_Homo sapiens_hsa05032 | 0.80674423 |
| 88 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.79193173 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76629432 |
| 90 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76300754 |
| 91 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.75944559 |
| 92 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.74828574 |
| 93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.74732298 |
| 94 | Lysine degradation_Homo sapiens_hsa00310 | 0.74456059 |
| 95 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71107155 |
| 96 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.69116997 |
| 97 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.67555674 |
| 98 | Basal transcription factors_Homo sapiens_hsa03022 | 0.65943567 |
| 99 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.65540153 |
| 100 | GABAergic synapse_Homo sapiens_hsa04727 | 0.62485831 |
| 101 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.61467806 |
| 102 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.61419317 |
| 103 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.60860604 |
| 104 | Alcoholism_Homo sapiens_hsa05034 | 0.60368440 |
| 105 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.60129836 |
| 106 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.58933573 |
| 107 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57643415 |
| 108 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.57052703 |
| 109 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.56452702 |
| 110 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.55993724 |
| 111 | Spliceosome_Homo sapiens_hsa03040 | 0.55108086 |
| 112 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.53957111 |
| 113 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.53095797 |
| 114 | Salivary secretion_Homo sapiens_hsa04970 | 0.52350244 |
| 115 | DNA replication_Homo sapiens_hsa03030 | 0.51688005 |
| 116 | Carbon metabolism_Homo sapiens_hsa01200 | 0.51617776 |
| 117 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50813405 |
| 118 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.49875418 |
| 119 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.47762305 |
| 120 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.47576778 |
| 121 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.47056697 |
| 122 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.47051677 |
| 123 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.46551235 |
| 124 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46402410 |
| 125 | Phagosome_Homo sapiens_hsa04145 | 0.46084997 |
| 126 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.45885217 |
| 127 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.44502057 |
| 128 | Amoebiasis_Homo sapiens_hsa05146 | 0.44380685 |
| 129 | Mineral absorption_Homo sapiens_hsa04978 | 0.43099871 |
| 130 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.42926206 |
| 131 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.41957261 |
| 132 | Purine metabolism_Homo sapiens_hsa00230 | 0.41850744 |
| 133 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.41834301 |
| 134 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.40889920 |
| 135 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.40651787 |
| 136 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.39967577 |
| 137 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.39390870 |
| 138 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.38852408 |
| 139 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.38433187 |
| 140 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37684225 |
| 141 | Melanogenesis_Homo sapiens_hsa04916 | 0.37655195 |
| 142 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.37600044 |
| 143 | Retinol metabolism_Homo sapiens_hsa00830 | 0.35555440 |
| 144 | Pertussis_Homo sapiens_hsa05133 | 0.35300191 |
| 145 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.35171050 |
| 146 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.35163563 |
| 147 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.34844758 |
| 148 | Circadian entrainment_Homo sapiens_hsa04713 | 0.34049997 |
| 149 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.33947577 |
| 150 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33670125 |
| 151 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.33501027 |
| 152 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.33137929 |

